Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harden, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harden, C. L.

Neurology 2002;59:S48-S55
© 2002 American Academy of Neurology

Neurology supplements are not peer-reviewed. Information contained in Neurology supplements represent the opinions of the authors and are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology.

The co-morbidity of depression and epilepsy

Epidemiology, etiology, and treatment

Cynthia L. Harden, MD

From the Comprehensive Epilepsy Center, Weill Medical College of Cornell University, New York, NY.

Address correspondence and reprint requests to Dr. Cynthia L. Harden, Comprehensive Epilepsy Center, Weill Medical College of Cornell University, 525 E 68th St., Room K-615, New York, NY 10021.

Article abstract Co-morbid depression is common in patients with epilepsy and is often undiagnosed. The manifestation of depression in epilepsy is multifaceted with many interacting neurobiological and psychosocial determinants, including clinical features of epilepsy (seizure frequency, type, foci, or lateralization of foci) and neurochemical or iatrogenic mechanisms. Depression is reported more frequently in patients with temporal lobe epilepsy (TLE) and left-sided foci, although not all studies support this finding. In patients with depression and epilepsy, optimal control of seizures should be attained first and foremost with appropriate anticonvulsant treatments including antiepileptic drugs (AEDs) and vagus nerve stimulation (VNS) therapy. Some anticonvulsant treatments (VNS, valproate, carbamazepine, lamotrigine, and gabapentin) have demonstrated mood improvement in epilepsy patients and may have therapeutic potential for this patient population. When antidepressants are necessary to treat depression in patients with epilepsy, selective serotonin reuptake inhibitors (SSRIs) and multireceptor antidepressants are considered first-line treatments. Electroconvulsive therapy is not contraindicated for treatment-resistant or psychotic depression. Depression must be recognized, diagnosed, and adequately treated in patients with epilepsy.




This article has been cited by other articles:


Home page
 J Child NeurolHome page
R. D. Sheth and B. E. Gidal
Topical Review: Optimizing Epilepsy Management in Teenagers
J Child Neurol, April 1, 2006; 21(4): 273 - 279.
[Abstract] [PDF]

Home page
 BrainHome page
I. Merlet, K. Ostrowsky, N. Costes, P. Ryvlin, J. Isnard, I. Faillenot, F. Lavenne, D. Dufournel, D. Le Bars, and F. Mauguiere
5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study
Brain, April 1, 2004; 127(4): 900 - 913.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. M. Pellock
Understanding co-morbidities affecting children with epilepsy
Neurology, March 9, 2004; 62(90052): S17 - 23.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.